Range Low Price High Price Comment
30 days $1.52 $2.00 Tuesday, 2nd Jul 2024 IMAB stock ended at $1.58. This is 2.47% less than the trading day before Monday, 1st Jul 2024. During the day the stock fluctuated 3.82% from a day low at $1.57 to a day high of $1.63.
90 days $1.52 $2.00
52 weeks $1.16 $3.17

Historical I-Mab prices

Date Open High Low Close Volume
Jul 02, 2024 $1.61 $1.63 $1.57 $1.58 146 104
Jul 01, 2024 $1.67 $1.67 $1.60 $1.62 103 103
Jun 28, 2024 $1.71 $1.73 $1.60 $1.67 110 682
Jun 27, 2024 $1.72 $1.77 $1.66 $1.69 99 552
Jun 26, 2024 $1.70 $1.76 $1.68 $1.71 163 139
Jun 25, 2024 $1.71 $1.74 $1.69 $1.72 53 135
Jun 24, 2024 $1.67 $1.73 $1.67 $1.72 85 036
Jun 21, 2024 $1.71 $1.72 $1.68 $1.68 90 778
Jun 20, 2024 $1.76 $1.77 $1.67 $1.69 185 772
Jun 18, 2024 $1.80 $1.81 $1.76 $1.77 150 200
Jun 17, 2024 $1.82 $1.84 $1.77 $1.82 145 841
Jun 14, 2024 $1.85 $1.86 $1.83 $1.84 98 306
Jun 13, 2024 $1.84 $1.86 $1.84 $1.86 63 883
Jun 12, 2024 $1.87 $1.87 $1.83 $1.85 221 829
Jun 11, 2024 $1.84 $1.86 $1.84 $1.86 132 665
Jun 10, 2024 $1.91 $1.91 $1.84 $1.86 182 112
Jun 07, 2024 $1.88 $1.89 $1.83 $1.88 256 154
Jun 06, 2024 $1.91 $1.93 $1.82 $1.87 372 020
Jun 05, 2024 $1.98 $2.00 $1.72 $1.90 1 062 790
Jun 04, 2024 $1.56 $2.00 $1.56 $1.88 2 088 173
Jun 03, 2024 $1.67 $1.67 $1.52 $1.58 290 580
May 31, 2024 $1.74 $1.75 $1.66 $1.66 159 222
May 30, 2024 $1.79 $1.79 $1.73 $1.74 48 518
May 29, 2024 $1.74 $1.78 $1.74 $1.77 88 756
May 28, 2024 $1.73 $1.75 $1.73 $1.74 178 146

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use IMAB stock historical prices to predict future price movements?
Trend Analysis: Examine the IMAB stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the IMAB stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About I-Mab

I-Mab I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinical trials to treat pediatric growth hormone deficiency; TJ107, a recombinant human IL-7, which is in Pha... IMAB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT